(Reuters) -Vaxart said on Wednesday it received an order to stop work on screening and enrollment for its COVID-19 mid-stage ...

San Diego CDMO TriLink BioTechnologies is reducing its headcount while its parent company, Maravai LifeSciences, moves ...

The HHS secretary recently canceled $500 million worth of BARDA contracts around mRNA vaccine research. But the U.S.

Doctors and scientists who spoke to HuffPost are worried for a multitude of reasons and want you to know that this will ...

Soligenix, Inc. (Nasdaq: SNGX) (Soligenix or the Company), a late-stage biopharmaceutical company focused on developing and commercializing products to treat rare diseases where there is an unmet ...

Advancing novel programs for respiratory viruses that pose pandemic threats or risk of serious illness, including SARS CoV2 (ratutrelvir) and influenza (Tivoxavir marboxil, TXM) Prioritization of ratu ...

Soligenix, Inc. (Nasdaq: SNGX) (Soligenix or the Company), a late-stage biopharmaceutical company focused on developing ...

VANGUARD has selected five companies for up to $200,000 in non-dilutive funding contracts and 10 companies for the 2025 ...

From the editorial, "While a virus may be more fear-inducing, ultra-processed food can prove just as life-shortening, albeit not quite as suddenly. This is not a new threat, of course. " ...

Reports Q2 revenue $2.7M vs. $57,000 last year. “Traws has made good progress this year towards our goal of bringing our antiviral candidates to ...

Advancing novel programs for respiratory viruses that pose pandemic threats or risk of serious illness, including SARS CoV2 ...

The Trump administration’s decision to halt nearly $500 million for mRNA vaccine research has made investors more hesitant to ...